ClearPoint Neuro Files 2025 Proxy Statement
Ticker: CLPT · Form: DEF 14A · Filed: Apr 9, 2025 · CIK: 1285550
| Field | Detail |
|---|---|
| Company | Clearpoint Neuro, Inc. (CLPT) |
| Form Type | DEF 14A |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
ClearPoint Neuro's proxy statement is out, detailing exec pay & equity awards for 2022-2024.
AI Summary
ClearPoint Neuro, Inc. filed its DEF 14A on April 9, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity awards granted and vested for the fiscal years 2022, 2023, and 2024. It also provides information on the company's former names, MRI Interventions, Inc. and Surgivision Inc.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and corporate governance, impacting their voting decisions on company leadership and strategy.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information on executive compensation and corporate governance, not indicating new or unusual risks.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for compensation details)
- 2023 — Fiscal Year (Compensation details provided)
- 2022 — Fiscal Year (Compensation details provided)
Key Players & Entities
- ClearPoint Neuro, Inc. (company) — Filer
- MRI Interventions, Inc. (company) — Former Company Name
- Surgivision Inc (company) — Former Company Name
- 20250409 (date) — Filing Date
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 9, 2025.
What fiscal years are covered by the compensation data in this filing?
The compensation data in this filing covers the fiscal years 2024, 2023, and 2022.
What were some of ClearPoint Neuro, Inc.'s former company names?
ClearPoint Neuro, Inc. was formerly known as MRI Interventions, Inc. and Surgivision Inc.
What is the Standard Industrial Classification (SIC) code for ClearPoint Neuro, Inc.?
The Standard Industrial Classification (SIC) code for ClearPoint Neuro, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 9, 2025 regarding ClearPoint Neuro, Inc. (CLPT).